Home›Stock Screener›Kronox Lab Sciences›Financial Statements

Kronox Lab Sciences Complete Financial Statements

6 Years of Data
2025 - 2020

In FYNone, Kronox Lab Sciences (KRONOX) reported revenue ₹105 Cr, net profit ₹26 Cr and EPS ₹7.00, with a net profit margin of 25.2% and ROE of 28.9%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see KRONOX share price.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 25.24% 2025 data
EBITDA Margin 34.95% 2025 data
Operating Margin 33.00% 2025 data
Return on Assets 26.26% 2025 data
Return on Equity 28.89% 2025 data

Balance Sheet Ratios

Equity Ratio 90.91% 2025 data
Asset Turnover 1.04 2025 data

KRONOX Revenue, Net Profit & EBITDA — Year-on-Year Growth

KRONOX YoY (March 2025 vs Period) — revenue +1.9%, expenses +3.0%. Explore Kronox Lab Sciences intrinsic price to estimate fundamental worth using multiple valuation models.

Revenue Growth
+1.9%
Year-over-Year
Expense Growth
+3.0%
Year-over-Year
Assets Growth
+33.8%
Year-over-Year
Equity Growth
+36.4%
Year-over-Year
Operating Cash Flow Growth
+82.4%
Year-over-Year
Investing Cash Flow Growth
-64.7%
Year-over-Year

KRONOX Income Statement — Revenue, EBITDA & Net Profit

Kronox Lab Sciences revenue ₹105 Cr, EBITDA ₹36 Cr, net profit ₹26 Cr, EPS ₹7.00 (None) — net profit margin 25.2%. Review KRONOX earnings valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 105 103 91 98 83 63 52
Expenses 69 67 62 74 63 48 39
EBITDA 36 36 30 24 21 16 13
Operating Profit Margin % 32.00% 33.00% 32.00% 23.00% 24.00% 24.00% 23.00%
Depreciation 2 1 1 2 2 2 1
Interest 0 0 0 0 0 0 0
Profit Before Tax 35 34 29 22 18 13 12
Tax 9 9 7 6 5 4 3
Net Profit 26 26 21 16 14 10 9
Earnings Per Share (₹) 7.00 6.91 5.81 4.29 3.49 2.40 343.75

KRONOX Balance Sheet — Assets, Liabilities & Shareholders' Equity

KRONOX total assets ₹99 Cr, total equity ₹90 Cr, total liabilities ₹ Cr (2025) — ROE 28.9%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 99 74 54 57 38 34
Current Assets 63 47 34 44 26 27
Fixed Assets 28 26 16 11 9 6
Capital Work in Progress 1 1 0 0 0 0
Investments 0 0 0 0 0 0
Other Assets 70 47 38 46 28 29
LIABILITIES
Total Liabilities
Current Liabilities 0 0 1 3 3 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 90 66 45 40 27 23
Share Capital 37 37 37 0 0 0
Reserves & Surplus 53 29 8 40 27 23

KRONOX Cash Flow Statement — Operating, Investing & Financing

Kronox Lab Sciences operating cash flow ₹31 Cr, investing ₹-28 Cr, financing ₹-2 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities 31 17 20 9 11 5
Investing Activities -28 -17 -7 -8 -3 -4
Financing Activities -2 0 -13 -1 -7 0
Net Cash Flow 0 0 0 1 1 0